Decisions have to be based on indecisive data
- Stuart Jon Spechler, chief, division of gastroenterology (SJSpechler@AOL.com)
- Dallas Department of Veterans Affairs Medical Center, Dallas, Texas 75216, USA
In Barrett's oesophagus the stratified squamous epithelium that normally lines the distal oesophagus is replaced by an abnormal columnar epithelium that has intestinal features.1 The abnormal epithelium (called specialised intestinal metaplasia) usually shows evidence of DNA damage that predisposes to malignancy,2 and most oesophageal adenocarcinomas seem to arise from this metaplastic tissue.3 Barrett's oesophagus affects mainly white men, among whom the incidence of oesophageal adenocarcinoma has more than quadrupled over the past few decades.4 The quandary is to know what to do to prevent Barrett's oesophagus from turning into oesophageal cancer.
Barrett's oesophagus develops as a consequence of chronic gastro-oesophageal reflux disease (GORD), and is usually discovered during endoscopy performed to evaluate the symptoms of reflux disease. Endoscopists recognise Barrett's oesophagus because the dull red of the metaplastic columnar epithelium contrasts sharply with the pale glossy normal squamous lining (figure).
Long segment Barrett's oesophagus. The dull red of the metaplastic columnar epithelium contrasts with the pale, glossy appearance of the normal squamous lining
Barrett's oesophagus is classified as long segment or short segment, depending on whether or not the specialised intestinal metaplasia extends 3 cm or more above the gastro-oesophageal junction.5 Among patients who have endoscopy for symptoms of reflux, long segment Barrett's oesophagus is found in 3-5% and short segment disease in 10-15%.1 Although it is not clear whether long and short …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012